Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.
Clarke JM, Simon GR, Mamdani H, Gu L, Herndon JE 2nd, Stinchcombe TE, Ready N, Crawford J, Sonpavde G, Balevic S, Nixon AB, Campa M, Gottlin EB, Li H, Saxena R, He YW, Antonia S, Patz EF Jr. Clarke JM, et al. Among authors: herndon je 2nd. Nat Commun. 2025 Jan 2;16(1):93. doi: 10.1038/s41467-024-55092-2. Nat Commun. 2025. PMID: 39747856 Clinical Trial.
Combination checkpoint blockade and laser interstitial thermal therapy in radiographically progressive non-small cell lung cancer brain metastases.
Haskell-Mendoza AP, Srinivasan ES, Gonzalez AT, Reason EH, Jackson JD, Flusche AM, Wachsmuth LP, Lerner E, Underwood D, Buckley ED, Zaidi SE, Herndon JE 2nd, Fecci PE. Haskell-Mendoza AP, et al. Among authors: herndon je 2nd. Neurooncol Adv. 2024 Dec 18;6(1):vdae207. doi: 10.1093/noajnl/vdae207. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39717437 Free PMC article.
Variation in Oral Board Examination Accommodations Among Specialties.
Rowe DG, Charles AJ, Luo EJ, Arango AM, Herndon JE 2nd, Hockenberry H, Shortell CK, Goodwin CR, Erickson MM. Rowe DG, et al. Among authors: herndon je 2nd. JAMA Netw Open. 2024 May 1;7(5):e2410127. doi: 10.1001/jamanetworkopen.2024.10127. JAMA Netw Open. 2024. PMID: 38713464 Free PMC article.
Automated segmentation of ablated lesions using deep convolutional neural networks: A basis for response assessment following laser interstitial thermal therapy.
Haskell-Mendoza AP, Reason EH, Gonzalez AT, Jackson JD, Sankey EW, Srinivasan ES, Herndon JE 2nd, Fecci PE, Calabrese E. Haskell-Mendoza AP, et al. Among authors: herndon je 2nd. Neuro Oncol. 2024 Jun 3;26(6):1152-1162. doi: 10.1093/neuonc/noad261. Neuro Oncol. 2024. PMID: 38170451 Free PMC article.
ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.
Jones JK, Zhang H, Lyne AM, Cavalli FMG, Hassen WE, Stevenson K, Kornahrens R, Yang Y, Li S, Dell S, Reitman ZJ, Herndon JE 2nd, Hoj J, Pendergast AM, Thompson EM. Jones JK, et al. Among authors: herndon je 2nd. Neurooncol Adv. 2023 Aug 7;5(1):vdad095. doi: 10.1093/noajnl/vdad095. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37781087 Free PMC article.
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Thompson EM, Landi D, Brown MC, Friedman HS, McLendon R, Herndon JE 2nd, Buckley E, Bolognesi DP, Lipp E, Schroeder K, Becher OJ, Friedman AH, McKay Z, Walter A, Threatt S, Jaggers D, Desjardins A, Gromeier M, Bigner DD, Ashley DM. Thompson EM, et al. Among authors: herndon je 2nd. Lancet Child Adolesc Health. 2023 Jul;7(7):471-478. doi: 10.1016/S2352-4642(23)00031-7. Epub 2023 Mar 30. Lancet Child Adolesc Health. 2023. PMID: 37004712 Free PMC article. Clinical Trial.
300 results